Psychiatric co-morbidity and substance use disorders: Treatment in parallel systems or in one integrated system

Marta Torrens, Paola C. Rossi, Roser Martinez-Riera, Diana Martinez-Sanvisens, Antoni Bulbena

Research output: Contribution to journalArticleResearchpeer-review

51 Citations (Scopus)

Abstract

Psychiatric co-morbidity among substance users refers to the simultaneous presence of at least another psychiatric disorder in a person diagnosed with a substance use disorder. Co-morbid patients represent a substantial number of people in treatment and present greater disorder severity from both the clinical and social perspectives than those people diagnosed with only one type of disorder. We present an overview of the current state of the art concerning the choice of site of treatment, the kind of intervention, the length of such treatment, and future goals, aiming to establish a more effective intervention, and finally so as to further improve clinical outcomes. © 2012 Informa Healthcare USA, Inc.
Original languageEnglish
Pages (from-to)1005-1014
JournalSubstance Use and Misuse
Volume47
Issue number8-9
DOIs
Publication statusPublished - 1 Jun 2012

Keywords

  • dual diagnosis
  • psychiatric co-morbidity
  • services
  • substance use
  • treatment

Fingerprint Dive into the research topics of 'Psychiatric co-morbidity and substance use disorders: Treatment in parallel systems or in one integrated system'. Together they form a unique fingerprint.

Cite this